Third quarter 2024 results - Sanofi

Sanofi Earns $5B Q3 Core Profit On Strong Dupixent And Vaccine …

1 week from now

Oct 25, 2024  · Sanofi Earns $5B Q3 Core Profit On Strong Dupixent And Vaccine Sales, Raises 2024 Forecast. On Friday, Sanofi SA (NASDAQ:SNY) reported a third-quarter business …

yahoo.com

Sanofi Q3 Earnings Beat, Dupixent, New Drugs, Vaccines Drive Sales

1 week from now

Oct 25, 2024  · Sanofi SNY reported third-quarter 2024 adjusted earnings of $1.57 per American depositary share, which beat the Zacks Consensus Estimate of $1.35 per share. Earnings of …

nasdaq.com

Sanofi Q3 Earnings Beat, Dupixent, New Drugs, Vaccines Drive Sales

1 week from now

Oct 25, 2024  · In 2024, Dupixent sales are expected to be around €13 billion. Our Take on SNY’s Q3 Results. Sanofi’s quarterly results were strong as it beat estimates for both earnings and …

zacks.com

Sanofi Outpaces Expectations In Third Quarter 2024

1 week from now

Oct 25, 2024  · Sanofi reported Q3 2024 sales growth of 15.7%, reaching 13.4 billion euros ($14.2 billion), with EPS up 12.2% to 2.86 euros. Growth was fueled by increased vaccine revenues, …

thepharmaletter.com

Press Release: Sanofi Q3: 15.7% Sales Growth Boosted By Earlier …

1 week from now

Sanofi Q3: 15.7% sales growth boosted by earlier-than-anticipated vaccine sales; 2024 business EPS guidance raised due to strong business performance. Paris, October 25, 2024. Q3 sales …

ft.com

ICICI Lombard Q3 Results: PAT Jumps 68% YoY To Rs 724 Crore, …

1 week from now

2 days ago  · The solvency ratio was 2.62x as of March 31, 2024. The earnings were announced post the market hours and ICICI Lombard shares on Friday ended at Rs 1,955 on the NSE, up …

indiatimes.com

Earnings Call: Sanofi Reports Robust Q3 Sales And Raises 2024 EPS ...

1 week from now

Oct 25, 2024  · Sanofi's strong Q3 2024 performance is reflected in its financial metrics from InvestingPro. The company's revenue growth of 7.48% in Q2 2024 aligns with the reported …

investing.com

Kotak Mahindra Bank Q3 Results Out. NII Rises 14.75%, PAT Jumps …

1 week from now

1 day ago  · Q3 results today: Kotak Mahindra Bank’s net interest income from October to December 2024 was ₹16,633.14 crore, up from ₹14,494.96 crore in Q3FY24 and ₹16,426.97 …

livemint.com

Sanofi Reports Strong Q3 Growth And Raises EPS Guidance

1 week from now

Oct 25, 2024  · Sanofi reported a robust 15.7% growth in sales for Q3 2024, driven by strong performances in its vaccine and pharmaceutical segments, notably with Dupixent sales rising …

nasdaq.com

AbbVie Reports Third-Quarter 2024 Financial Results | AbbVie

1 week from now

Oct 30, 2024  · Full-Year 2024 Outlook. AbbVie is raising its adjusted diluted EPS guidance for the full year 2024 from $10.67 - $10.87 to $10.90 - $10.94, which includes an unfavorable impact …

abbvie.com

Press Release: Sanofi Q3: 15.7% Sales Growth Boosted By Earlier …

1 week from now

Oct 25, 2005  · Sanofi Q3: 15.7% sales growth boosted by earlier-than-anticipated vaccine sales; 2024 business EPS guidance raised due to strong business performance. Paris, October 25, …

sanofi.com

Netweb Technologies Q3FY25 Results: Net Profit Rises 16% To Rs …

1 week from now

1 day ago  · Domestic IT server maker Netweb Technologies posted a 16.56 per cent growth in profit to Rs 30.32 crore in the third quarter ended December 31, 2024, driven by demand for …

business-standard.com

Cytokinetics Sets PDUFA Target Action Date For Aficamten On

1 week from now

6 days ago  · FMR LLC added 571,126 shares (+5.0%) to their portfolio in Q3 2024 VOLORIDGE INVESTMENT MANAGEMENT, LLC removed 542,009 shares (-97.6%) from their portfolio in …

nasdaq.com

Piedmont Lithium Reports Strong Q3 2024 Results - Markets Insider

1 week from now

Nov 12, 2024  · Piedmont Lithium Reports Strong Q3 2024 Results. TipRanks. Nov. 12, 2024, 10:04 PM. ... The company reported $27.7 million in revenue for Q3 2024, emphasizing its …

businessinsider.com